← Back to headlines
J&J to Acquire Firefly Bio for $1 Billion, Incyte Buys Vega Therapeutics
Johnson & Johnson is set to acquire cancer drug technology developer Firefly Bio for $1 billion, while Incyte announced its acquisition of Vega Therapeutics for $1.25 billion. These deals highlight significant activity in the pharmaceutical and biotechnology sectors.
8 Jun, 11:12 — 8 Jun, 12:28
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: seeking-alpha · 8 Jun, 11:12|Full coverage: 2 · 1h|Window: 1h
Left-leaningCenterRight-leaning
